The 13th Annual World ADC London returns in 2023 as Europe’s longest standing and definitive antibody-drug conjugate event - and it’s back bigger and better than before! With the recent approval of Astrazeneca and Daiichi Sankyo’s DESTINY-Breast04, supporting Enhertu's use in HER2-low breast cancer as a new therapeutically targetable category, the
13-16 March 2023